← All stories
Markets
Hikma Pharmaceuticals LSE:HIK FTSE 100 Brings Pipeline And Ownership News Back Into Focus For UK Shares
Highlights Hikma Pharmaceuticals is in focus because generic and injectable medicines exposure amid resilient healthcare demand. Spire Healthcare Group (LSE:SPI) and AstraZeneca (LSE:AZN) show that the category is responding selectively aro…
Covered by 1 outlet
All coverage · 1 article